The aims of this study were to assess bone mineral density (BMD) and content (BMC), osteocalcin, serum telopeptide, PTH and vitamin D in alcoholics, and to determine if a 6-month period of abstinence leads to changes in these parameters. Methods: Serum osteocalcin, insulin-like growth factor 1 (IGF-1), telopeptide (40 patients) and 1,25 dihydroxyvitamin D, were measured in 28 controls and 77 alcoholic patients, 48 of whom were evaluated again 6 months later. All patients underwent whole-body assessment of BMD by a Hologic QDR-2000 (Waltham, MA, USA) bone densitometer, at the beginning of the study and 6 months later. Results: Patients showed higher serum telopeptide levels (0.59 ± 0.40 versus 0.19 ± 0.10 nmol/100 ml, P < 0.001), lower IGF-1 [median = 49, interquartile range (IQR) = 31-121 ng/ml versus 135, IQR = 116-237 ng/ml, P < 0.001], vitamin D [26.5, IQR = 17.0-37.8 pg/ml versus 82.4 (IQR = 60.9-107.4 pg/ml, P < 0.001] and osteocalcin (2.1, IQR = 1.1-3.6 ng/ml versus 6.65, IQR = 4.9-8.8 ng/ml, P < 0.001) than those in controls. Patients also showed lower BMD values, Z-and T-scores at many levels of the skeleton and reduced total BMC. After 6 months, those who continued drinking showed a loss of bone mass, whereas those who abstained showed either no change or increase, differences being especially marked at pelvis, right arm and total BMD and BMC. Simultaneously, abstainers showed a significant increase in osteocalcin (versus a decrease among those who continued drinking). Serum telopeptide increased in both groups. Conclusion: Ethanol consumption leads to osteopenia, and decreased serum osteocalcin, which improve with abstinence, whereas those who continue drinking show a worsening of both parameters.
INTRODUCTION
Since the classic observations by Saville (1965) and Oppenheim (1977) on the bone fragility and high incidence of fractures observed in the so-called Battered alcoholic syndrome, and despite some studies with opposite results (Baron et al., 2001) , several reports have stressed the importance of ethanol consumption in the pathogenesis of osteoporosis (Spencer et al., 1986; Peris et al., 1995a Peris et al., , 1995b . Indeed, osteoporosis is frequently observed in the alcoholic patient (Leslie et al., 2003) . Ethanol decreases bone formation (Diamond et al., 1989) in a dose-dependent fashion (Turner, 2000) , mainly through a direct toxic effect on osteoblast function, which may also account for an inhibition of bone growth in experimental animals (Wezeman et al., 2000) and, possibly, in humans (González-Reimers et al., 2007) . It also alters, both directly and indirectly, bone mineral metabolism, including parathyroid hormone (PTH), vitamin D, testosterone, IGF-1 and cortisol levels. Recent research has also shown that several cytokines, which become altered in alcoholics, such as TNF alpha and IL-6, regulate the OPG/RANKL system (Lorenzo 2000; Yamada et al., 2002; Nagata et al., 2003) and may play a role in ethanolinduced bone loss (García-Valdecasas-Campelo et al., 2006) . In this sense, ethanol seems to stimulate IL-6 production, causing via induction of RANKL, activation of osteoclastogenesis (Dai et al., 2000) . Finally, other factors, such as irregular feeding and social margination, González-Reimers et al., 2005) , as well as protein deficiency (Molina-Pérez et al., 2000) , also contribute to bone loss in alcoholics.
As in other ethanol-mediated systemic alterations, such as myocardiopathy (Nicolas et al., 2002) or brain atrophy (Pfefferbaum et al., 1995) in which reduction and/or withdrawal of ethanol intake partially reverses the lesion, alcohol abstinence may improve the alterations observed in bone. Some data point that age-matched abstaining women showed a higher bone mass than actually drinking women, although lower than that of non-alcohol-abusing women (Clark et al., 2003) . Other authors have reported that abstainers show increased bone formation (osteoid, bone GLA protein) compared with active drinkers (Crilly et al., 1988; Diamond et al., 1989) , so that abstainers for at least 2 years have biochemical markers of bone turnover similar to those of the controls (Lindholm et al., 1991) . However, bone changes observed along several months in individuals who stop drinking or not is less well studied. This work was performed in order to analyse the effect of alcohol abstinence on bone changes observed in alcoholic individuals who stop drinking compared with those who did not in a second evaluation performed 6 months after a basal one.
PATIENTS AND METHODS

Patients and controls
We included 77 alcoholic patients (9 women) consecutively admitted to our hospitalization unit. All of them were heavy drinkers of >150 g ethanol/day (204 ± 82 g/day) for prolonged time periods (28.4 ± 11.4 years). The mean age was 50.1 ± 11.7 years. The total amount of ethanol consumed until the inclusion in the study was 30.66 ± 16.62 kg ethanol/kg body weight (median = 26.89; interquartile range = 17.84-46.54). The control group consisted of 28 sanitary workers (3 women), aged 49.8 ± 9.2 years, drinkers of <10 g ethanol day.
Although the main objective of this study was to determine the effect of abstinence on bone metabolism, patients were also categorized in cirrhotics and non-cirrhotics according to clinical grounds and ultrasound findings, and to liver biopsy in doubtful cases (eight patients). Also, in six patients, liver biopsy was clinically indicated, but it could not be performed due to several reasons; these patients were excluded from the comparisons between cirrhotics and non-cirrhotics. After giving informed consent, patients and controls (Table 1 ) underwent an assessment of bone mineral density (BMD) by double energy X-ray absorptiometry (DEXA) at the lumbar spine and hip, and also whole-body assessment of BMD and bone mineral content (BMC), recording BMD, Z scores and T scores for the femoral neck, trochanter, Ward's triangle, intertrochantereal area, total hip and lumbar spine, and (in 72 patients) BMD at right and left legs and arms, thoracic and lumbar spine, pelvis, and right and left ribs, with a HOLOGIC QDR-2000 (Waltham, MA, USA).
In addition, subjective nutritional evaluation was performed to all but two patients as follows. We examined the muscle masses of the upper and lower limbs and of the temporal muscle, defining two degrees of atrophy (severe, moderate) and absence of atrophy. We assigned 2, 1 and 0 points to each category, respectively. We also recorded, by physical examination, the fat loss on the cheek and abdomen, Bichat's fat and subcutaneous fat atrophy, and classified them in a similar way. We defined a score (SNS), based on the sum of the assigned points, for which the poorest value was 10 and 0 the best one. We further classified our patients under well nourished (0-2 points), moderately undernourished (3-4 points) and severely undernourished (5-10 points), since this classification is related to prognosis (Hernández-Plasencia et al., 1991) .
We recorded body mass index (BMI) and determined serum bilirubin, prothrombin activity and serum albumin, mean corpuscular volume (MCV) and serum gamma-glutamyl transpeptidase (GGT). We also collected blood samples after overnight fast. Samples were stored at −80
• until the following hormones and biochemical markers were determined.
We determined serum osteocalcin, by immunometric chemiluminiscent assay (recovery = 97-121%; variation coefficients of assays ranging from 3.5-7.1%; DPC, Los Angeles, CA, USA), as a marker of bone synthesis, and C-terminal telopeptide of type I collagen (CrossLaps), by one step ELISA, with a recovery ranging from 94-107% and an intra-and interassay variation coefficient ranging 4.7-4.9% and 5.4-8.1%, respectively (Osteometer Bio Tech A/S, Herlev, Denmark), as a marker of bone breakdown. This parameter was determined only to 40 patients (five women) and 24 controls at inclusion in the study, and to 35 of those who were evaluated 6 months later.
We also determined serum IGF-1 (Chemiluminiscent assay, DPC, Los Angeles, CA, USA), 1,25 dihydroxyvitamin D3 [radioimmunoassay (RIA), Nichols, San Juan Capistrano, CA, USA], parathyroid hormone (PTH) and routine laboratory evaluation. The study protocol was approved by the local ethical committee of our Hospital and conforms to the ethical guidelines of the 1975 Declaration of Helsinki.
Patients were advised to stop alcohol intake and to change the style of life (daily walking, eating three meals a day, with abundant milk products), and were cited for a second assessment 6 (±1) months later, recording, at that time, the same parameters. Nine patients showed T-scores at the femoral neck and/or lumbar spine in the osteoporotic range, and were offered treatment with biphosphonates; they were excluded from this second part of the study. Four patients died within these 6 months: Of the remaining 64 patients, only 48 attended the second evaluation. Patients were asked if they had completely stopped alcohol consumption or not, an information which was contrasted with the patients' relatives and with analytical data, such as serum GGT and mean corpuscular volume (MCV). If these data were altered, but the patient denied alcohol intake, we again asked patients and relatives.
Statistics
The Kolmogorov-Smirnov test was used to test for normal distribution, a condition not fulfilled by PTH, vitamin D, IGF-1 and osteocalcin. Therefore, non-parametric tests, such as Mann-Whitney's U test and Kruskall-Wallis, were used to analyse differences of these parameters between groups. Student's t test, variance analysis and Pearson's correlation analysis were used with the remaining parameters, whereas Spearman's rho (instead of Pearson's correlation) was utilized in the case of non-parametric variables. We analysed if there were differences in changes in total BMC and BMD parameters between abstainers and non-abstainers at the second visit compared with the first one, using general lineal model for repeated measures. We also calculated the differences in BMD values at the first and second determinations, and analysed, using Student's t-test, if these changes were significantly different between abstainers and non-abstainers. Some patients lost BMD, and some others gained BMD; we analysed, by Table 2 . Bone mineral density (T score and Z score) of lumbar spine and different parts of the hip in patients and controls. Results are given as mean ± means of chi-square, whether there was a different behaviour between abstainers and non-abstainers regarding bone gain or bone loss.
RESULTS
Differences in clinical and biochemical parameters between patients and controls are shown in Table 1 , whereas BMD values and T-and Z-score values for lumbar spine and hip of patients and controls are shown in Tables 2 and 3 . Decreased bone mineral density was observed in the included patients, who showed lower Z-scores than controls at different places. BMD at various levels of the skeleton, such as left leg (r = −0.28), right leg (r = −0.28), lumbar spine (r = −0.26) and Ward's triangle (r = −0.27, P < 0.05 in all cases) showed inverse relationships with the total amount of ethanol consumed (kg ethanol/kg body weight). In a similar way, patients in the highest quartile of ethanol consumption showed, in general, lower BMD than patients in the lowest quartile, differences becoming statistically significant at right leg (t = 2.35, P = 0.03), left leg (t = 2.27, P = 0.03), lumbar spine (t = 2.48, P = 0.02), Ward's triangle (t = 3.63, P < 0.001) and total body BMD (t = 2.38, P = 0.025), although those with higher ethanol consumption were also older (F = 4.19, P = 0.009). We observed some differences between the 68 men and the 9 women included in the study, despite a nearly identical age (women = 51.0 ± 15.3 years; men = 49.98 ± 10.34 years). Women showed lower BMD values at right arm (0.65 ± 0.03 g/cm 2 ) and left arm (0.66 ± 0.05 g/cm 2 ), versus 0.81 ± 0.09 and 0.81 ± 0.08 g/cm 2 for men, respectively (P < 0.001 in both cases); ribs (0.51 ± 0.1 g/cm 2 for women and 0.61 ± 0.1 g/cm 2 for men, P < 0.001), legs (men = 1.23 ± 0.1 g/cm 2 at each leg; women = 1.07 ± 0.03 at left leg and 1.08 ± 0.03 at right leg, P < 0.001 in both cases) and subtotal BMD (0.87 ± 0.04 g/cm 2 for women and 0.99 ± 0.09 for men, P < 0.001), but higher lumbar spine T-score values (−0.67 ± 1.22 versus −1.27 ± 1.15, P = 0.006). No differences existed regarding osteocalcin, PTH, vitamin D, IGF-1 or serum telopepetide between men and women.
Cirrhotic patients (diagnosed on clinical grounds and liver ultrasound in all but eight cases, who were subjected to liver biopsy) showed, in general, lower BMD than non-cirrhotic patients (Tables 4 and 5) , despite a non-significant age difference.
Of the included patients, 47% were moderately or severely undernourished, according to SNS. Although significant correlations were observed between nutritional score and total BMC (ρ = −0.36), BMD (ρ = −0.31), left arm (ρ = −0.27) right arm (ρ = −0.29), left ribs (ρ = −0.25), right ribs (ρ = −0.24), lumbar spine (ρ = −0.35), pelvis (ρ = −0.41), right leg (ρ = −0.28, P = 0.02) and left leg (ρ = −0.29, P < 0.05 in all cases), statistically significant differences between normonourished, moderately undernourished and severely undernourished patients were only observed at lumbar spine and pelvis BMD (Figs. 1 and 2) .
Nine patients showed T-score values below −2.5 either at lumbar spine and/or at femoral neck. These patients were advised to take antiresorptive medication (alendronate 70 mg/weekly), so they were not included in the second part of the study.
In the remaining patients, when changes in BMD or BMC were compared between patients who drank and those who did not drink during the 6-month period between the first and the second BMD assessment, we observed that patients who did not drink alcoholic beverages during the observation period showed no changes in BMD, in contrast with patients who did drink during this period, who lost BMD (Tables 6 and 7) . These differences were statistically significant regarding total BMC and BMD, right arm BMD and pelvis BMD, as shown in Fig. 3 . As we see, these changes were accompanied by changes in serum osteocalcin, levels of which increased markedly among abstainers (reaching 4.43 ± 3.83 ng/ml), whereas suffered no change among non-abstainers; on the other hand, serum telopeptide values showed a non-significant trend to increase during the observational period, both abstainers and non-abstainers showing a parallel increase in their values. Regarding hormones, whereas no changes were observed in IGF-1 values, serum vitamin D showed a marked increase in those who withheld alcohol intake. PTH showed a non-significant trend to increased values among the abstainers during the observational period. When patients were grouped in those who lost BMD and those who did not loose BMD, in relation to alcohol abstinence or not, the proportion of those who lost bone was significantly or nearly significantly higher among those who continued drinking (90% versus 55.6%, P = 0.011, at third lumbar vertebra; 80% versus 53.6% at total hip, P = 0.055; 86.7% versus 50%, P = 0.018, at left arm; 87.5% versus 60.7%, P = 0.06, at lumbar spine; and 87.5% versus 57.14% at pelvis, P = 0.037). In Tables 6 and 7 , we show both basal BMD values and those observed 6 months later, and the statistical significance of the comparisons of differences in basal and 6-month BMD between abstainers and non-abstainers. It is noteworthy that basal BMD values showed a trend to higher values among the abstainers, despite a similar age [50.2 ± 12.4 years among (future) abstainers versus 50.0 ± 10.2 years, t = 0.09 among non-abstainers] and ethanol consumption (187 ± 65 g/day versus 212 ± 94 g/day respectively; t = 1.19, P = 0.24).
DISCUSSION
As expected, in accordance with other authors (Oppenheim, 1977; Lindsell et al., 1982; Schnitzler and Solomon, 1984; Wilkinson et al., 1985; Lalor et al., 1986; Lindholm et al., 1991; Peris et al., 1995a Peris et al., , 1995b , we found osteopenia in alcoholics; indeed, in nine cases (11.7%), T-score values were clearly in the osteoporotic range. This is not surprising, since after the first observations performed by Saville (1965) , several authors have described osteoporosis in alcoholics, which is more intense when liver cirrhosis is also present (Farley et al., 1985; Feitelberg et al., 1987; Jorge-Hernández et al., 1988; Diamond et al., 1989; Peris et al., 1992; Santolaria et al., 2000; García-Valdecasas-Campelo et al., 2006) , a conclusion fully in accordance with our results. As commented, ethanol itself may impair bone synthesis, but several other factors, such Table 6 . Bone mineral density (g/cm 2 ) and T-score values at different parts of the skeleton in abstainers and non-abstainers . Changes in BMD (g/cm 2 ), BMC (g), osteocalcin (ng/ml), telopeptide (in ng/ml) and serum vitamin D (pg/ml) during the study period in abstainers and non-abstainers. P value refers to the statistical significance of the differences of the changes experienced by BMD between abstainers and non-abstainers.
as irregular feeding, social margination, liver disease and poor nutrition, may also contribute. Indeed, in our study, the total amount of ethanol consumed is related to bone loss, a result not only explainable by the toxic effect of ethanol itself but also because drinkers during longer time are also older. We also found a relation between impairment of nutritional status and decreased bone mass, in accordance with previous reports , with experimental studies (Molina-Pérez et al., 2000) and with documented effects of protein deficiency on bone metabolism (Bourrin et al., 2000a (Bourrin et al., , 2000b . Also, alcoholic women showed lower BMD than males at various sites of the skeleton. Although a gender-related effect of ethanol on bone cannot be excluded, the number of women included in the study is small, so firm conclusions cannot be drawn from this result. However, the principal aim of this study was to analyse the effects of prolonged abstinence on bone alterations. We showed that alcohol abstinence is clearly associated with an increase in bone mass, which is statistically significant at various sites of the skeleton. In 1993, González-Calvin et al. reported that alcoholics showed an increase in bone Gla protein after 7 days of abstinence; other authors have also reported a relation between osteocalcin and days of abstinence (Peris et al., 1992) . However, we have not found a study in which bone changes were compared in the same patients after a prolonged period of abstinence. The results are striking: as shown in Fig. 3 , alcohol abstinence leads to pronounced increases in biochemical markers of bone synthesis-such as osteocalcin-and in vitamin D, a hormone involved in bone mineralization. Indeed, decreased vitamin D levels have been reported in alcoholics (Malik et al., 2009) , in possible relation with the effect of alcohol itself on vitamin D absorption, altered biliary secretion, accompanying malnutrition or decreased sun exposure.
The increase in osteocalcin levels observed in the abstinent patients was also accompanied by a relatively small increase in serum telopeptide, reflecting not only increased bone synthesis during abstinence but also a trend to increased bone breakdown. Therefore, in alcoholic patients, it seems that ethanol leads to osteopenia due to both decreased synthesis and increased bone resorption. Both osteocalcin and vitamin D levels increased in those who stopped drinking, indicating that low bone synthesis and mineralization recover with abstinence. Other authors have also reported depressed bone synthesis in alcoholics (Santori et al., 2008) , as well as in experimental animals (Sibonga et al., 2007) , and, as mentioned, increased osteocalcin values in alcoholics who stopped drinking, compared with those who did not (Diamond et al., 1989) .
Although a general agreement exists regarding the effect of ethanol on bone synthesis, results regarding bone breakdown are less consistent (Schnitzler and Solomon, 1984; Diamond et al., 1989; Dai et al., 2000; Turner, 2000) . In this study, serum telopeptide levels were higher in alcoholics than those in controls, in accordance with the results reported by other researchers, such as Schnitzler and Solomon (1984) or Dai et al. (2000) . However, serum telopeptide increased even more -although not significantly-in both abstinent and nonabstinent patients (Fig. 3) . This suggests that factors other than ethanol consumption, not identified in this study, may account for increased bone breakdown in alcoholics.
It is noteworthy that the mere abstinence led to increased bone mass or, at least, no bone loss in >40% of patients, in sharp contrast with those who continued drinking, the majority of whom (85-87% depending on which part of the skeleton was analysed) lost bone. Evidently, our results do not support any protective effect of ethanol on bone function and metabolism, at least of heavy alcohol consumption. On the contrary, it clearly shows that ethanol plays a deleterious effect on bone mass and bone density, and that ethanol abstinence corrects these alterations. However, we cannot exclude that factors other than ethanol itself, not addressed in this study, also contribute to the increase in bone mass. Probably, alcoholics who did not drink more also changed their life habits including regular physical activity, adequate dietary ingestion and, in general, a more healthy style of life. In any case, in this study, we show that alcoholics have decreased bone mass, due both to decreased bone synthesis and increased resorption, and that if these alcoholics stop drinking, bone mass increases and biochemical markers of bone synthesis tend to normalize.
